Palisade Bio PALI
NASDAQ PALI
$1.14 -0.05 (-4.20%)
As of: Nov 10, 2026 · 1:56 PM EST

Palisade Bio (PALI) Net Long-Term Debt Issued (Repaid) (2012 - 2017)

Updated

Palisade Bio (PALI) reported Non-Current Debt of $94,000 for Q4 2020.

Analysis

Palisade Bio (PALI) Net Long-Term Debt Issued (Repaid) (2012 - 2017) Analysis & Trends

Dating back to Q1 2013, Palisade Bio's Non-Current Debt record includes 14 quarters.

  • Non-Current Debt has a five-year compound annual growth rate of -51.2% (FY2015 to FY2020).
  • The Q4 2020 figure ranks as the highest quarterly Non-Current Debt in data going back to Q1 2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net LT Debt (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -1.00 Mn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 9.98 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn -
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -3.05 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn -19.00 Mn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 Palisade Bio 249.43 Mn -147.01 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2017 -2.54 Mn
Mar 31, 2017 -1.22 Mn
Dec 31, 2016 -1.19 Mn
Sep 30, 2016 -1.16 Mn
Jun 30, 2016 -1.13 Mn
Mar 31, 2016 -1.10 Mn
Dec 31, 2015 -1.15 Mn
Dec 31, 2014 4.20 Mn
Sep 30, 2014 -492,230.00
Jun 30, 2014 -720,305.00
Mar 31, 2014 -704,818.00
Mar 31, 2013 7.55 Mn
Dec 31, 2012 16,272.00
Sep 30, 2012 -16,272.00
API Access

Palisade Bio Net Long-Term Debt Issued (Repaid) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=PALI&period=max&api_key=YOUR_API_KEY